ASELLACRIN

Welcome to the Brand page for “ASELLACRIN”, which is offered here for Pharmaceutical preparation, somatropin for use in treating growth failure due to a deficiency of pituitary growth hormone;.

Its status is currently believed to be active. Its class is unavailable. “ASELLACRIN” is believed to be currently owned by “SERONO LABORATORIES, INC.”

Owner:
SERONO LABORATORIES, INC.
Owner Details
Description:
Pharmaceutical Preparation, Somatropin for Use in Treating Growth Failure Due to a Deficiency of Pituitary Growth Hormone;
Categories: PHARMACEUTICAL PREPARATION NAMELY